News & Publications

Breakthroughs in Cancer Immunotherapy Webinar: Dr. Rolf Brekken, Reactivating Your Immune System to Fight Cancer

On May 28, 2014, Rolf Brekken, Ph.D., an associate professor in the departments of surgery and pharmacology at UT Southwestern Medical Center, provided information on how cancers evade the immune system and what treatments and combination of treatments, including bavituximab and other immune activators, can be used to counter tumor-induced immune suppression, helping your immune system fight cancer more effectively.

This 45-minute online webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy webinar series, was generously supported by Peregrine Pharmaceuticals, Inc.

Dr. Brekken’s laboratory studies how therapy affects the tumor microenvironment and how stromal elements influence response to therapy. Dr. Brekken received his B.A. in Biology from Luther College and his Ph.D. from University of Texas Southwestern Medical Center where he trained under Philip E. Thorpe, Ph.D. His graduate studies were focused on developing novel therapies that target the vascular compartment of tumors. He was a postdoctoral fellow in the Department of Vascular Biology at the Hope Heart Institute in Seattle, WA, where he studied how the extracellular matrix contributes to vascular function and tumor progression. He joined the Department of Surgery at UT Southwestern as faculty in 2002 and was promoted to associate professor with tenure in 2009. He is also a member of the Simmons Comprehensive Cancer Center at UT Southwestern.

Dr. Brekken’s laboratory studies how therapy affects the tumor microenvironment and how stromal elements influence response to therapy. Dr. Brekken received his B.A. in Biology from Luther College and his Ph.D. from University of Texas Southwestern Medical Center where he trained under Philip E. Thorpe, Ph.D. His graduate studies were focused on developing novel therapies that target the vascular compartment of tumors. He was a postdoctoral fellow in the Department of Vascular Biology at the Hope Heart Institute in Seattle, WA, where he studied how the extracellular matrix contributes to vascular function and tumor progression. He joined the Department of Surgery at UT Southwestern as faculty in 2002 and was promoted to associate professor with tenure in 2009. He is also a member of the Simmons Comprehensive Cancer Center at UT Southwestern. - See more at: http://cancerresearch.org/news-publications/our-blog/may-2014/reactivating-your-immune-system-to-fight-cancer#sthash.0yxZb3r4.dpufDr. Brekken’s laboratory studies how therapy affects the tumor microenvironment and how stromal elements influence response to therapy. Dr. Brekken received his B.A. in Biology from Luther College and his Ph.D. from University of Texas Southwestern Medical Center where he trained under Philip E. Thorpe, Ph.D. His graduate studies were focused on developing novel therapies that target the vascular compartment of tumors. He was a postdoctoral fellow in the Department of Vascular Biology at the Hope Heart Institute in Seattle, WA, where he studied how the extracellular matrix contributes to vascular function and tumor progression. He joined the Department of Surgery at UT Southwestern as faculty in 2002 and was promoted to associate professor with tenure in 2009. He is also a member of the Simmons Comprehensive Cancer Center at UT Southwestern.